Anti-SGK1 antibody [Y238]
- RabMAb
- Recombinant
- What is this?
Be the first to review this product! Submit a review
|
(26 Publications)
Rabbit Recombinant Monoclonal SGK1 antibody. Suitable for IHC-P, WB, Flow Cyt (Intra) and reacts with Human, Mouse samples. Cited in 26 publications.
View Alternative Names
SGK, SGK1, Serine/threonine-protein kinase Sgk1, Serum/glucocorticoid-regulated kinase 1
- Flow Cyt (Intra)
Unknown
Flow Cytometry (Intracellular) - Anti-SGK1 antibody [Y238] (AB32374)
Overlay histogram showing HEK293 cells stained with ab32374 (red line). The cells were fixed with 80% methanol (5 min) and then permeabilized with 0.1% PBS-Tween for 20 min. The cells were then incubated in 1x PBS / 10% normal goat serum / 0.3M glycine to block non-specific protein-protein interactions followed by the antibody (ab32374, 1/100) for 30 min at 22°C. The secondary antibody used was DyLight® 488 goat anti-rabbit IgG (H+L) (ab96899) at 1/500 dilution for 30 min at 22°C. Isotype control antibody (black line) was rabbit IgG (monoclonal) (1μg/1x106 cells) used under the same conditions. Acquisition of >5,000 events was performed. This antibody gave a positive signal in HEK293 cells fixed with 4% paraformaldehyde (10 min)/permeabilized with 0.1% PBS-Tween for 20 min used under the same conditions.
- IHC-P
Unknown
Immunohistochemistry (Formalin/PFA-fixed paraffin-embedded sections) - Anti-SGK1 antibody [Y238] (AB32374)
ab32374, at a 1/50 dilution, staining SGK1 in paraffin embedded human kidney carcinoma tissue sections by Immunohistochemistry.
Perform heat mediated antigen retrieval with citrate buffer pH 6 before commencing with IHC staining protocol.
Perform heat mediated antigen retrieval with citrate buffer pH 6 before commencing with IHC staining protocol.
- WB
Unknown
Western blot - Anti-SGK1 antibody [Y238] (AB32374)
All lanes:
Western blot - Anti-SGK1 antibody [Y238] (ab32374) at 1/500 dilution
Lane 1:
A431 cell lysate
Lane 2:
NIH3T3 cell lysate
Predicted band size: 48 kDa
Observed band size: 57 kDa
false
Related conjugates and formulations (10)
-
665 Alexa Fluor® 647
Alexa Fluor® 647 Anti-SGK1 antibody [Y238]
-
578 PE
PE Anti-SGK1 antibody [Y238]
-
660 APC
APC Anti-SGK1 antibody [Y238]
-
HRP Anti-SGK1 antibody [Y238]
-
519 Alexa Fluor® 488
Alexa Fluor® 488 Anti-SGK1 antibody [Y238]
-
617 Alexa Fluor® 594
Alexa Fluor® 594 Anti-SGK1 antibody [Y238]
-
603 Alexa Fluor® 568
Alexa Fluor® 568 Anti-SGK1 antibody [Y238]
-
565 Alexa Fluor® 555
Alexa Fluor® 555 Anti-SGK1 antibody [Y238]
-
Anti-SGK1 antibody [Y238] - BSA and Azide free
-
775 Alexa Fluor® 750
Alexa Fluor® 750 Anti-SGK1 antibody [Y238]
Reactivity data
Product details
Patented technology
Our RabMAb® technology is a patented hybridoma-based technology for making rabbit monoclonal antibodies. For details on our patents, please refer to RabMAb® patents.
What are the advantages of a recombinant monoclonal antibody?
This product is a recombinant monoclonal antibody, which offers several advantages including:
- - High batch-to-batch consistency and reproducibility
- - Improved sensitivity and specificity
- - Long-term security of supply
- - Animal-free batch production
For more information, read more on recombinant antibodies.
Properties and storage information
Form
Purification technique
Storage buffer
Shipped at conditions
Appropriate short-term storage conditions
Appropriate long-term storage conditions
Aliquoting information
Storage information
Supplementary information
This supplementary information is collated from multiple sources and compiled automatically.
Biological function summary
SGK1 regulates ion transport cell proliferation and survival pathways. SGK1 is not usually part of large protein complexes but interacts dynamically with other proteins to exert its effects. It plays a major role in regulating sodium channels in the kidney therefore modulating sodium balance and blood pressure. It also affects various cell survival mechanisms influencing cell growth and apoptosis in response to physiological cues.
Pathways
SGK1 is involved in the PI3K/AKT/mTOR signaling pathway and the WNK/SPAK pathway. These pathways influence cellular growth metabolism and ion transport. SGK1 shares pathway relevance with proteins like AKT1 and mTOR in the PI3K/AKT/mTOR axis impacting various metabolic and growth-related cellular processes. In the WNK/SPAK pathway SGK1 regulates ion channels in collaboration with WNK kinases affecting electrolyte balance.
Product protocols
- Visit the General protocols
- Visit the Troubleshooting
Target data
Publications (26)
Recent publications for all applications. Explore the full list and refine your search
Immunity, inflammation and disease 12:e70072 PubMed39555740
2024
Applications
Unspecified application
Species
Unspecified reactive species
Frontiers in cardiovascular medicine 11:1359734 PubMed38903966
2024
Applications
Unspecified application
Species
Unspecified reactive species
Journal of cerebral blood flow and metabolism : official journal of the International Society of Cerebral Blood Flow and Metabolism 44:1145-1162 PubMed38235747
2024
Applications
Unspecified application
Species
Unspecified reactive species
JVS-vascular science 4:100124 PubMed37920479
2023
Applications
Unspecified application
Species
Unspecified reactive species
Frontiers in pharmacology 14:1200843 PubMed37346292
2023
Applications
Unspecified application
Species
Unspecified reactive species
Journal of biomedical science 30:13 PubMed36803854
2023
Applications
Unspecified application
Species
Unspecified reactive species
Clinical epigenetics 14:131 PubMed36266728
2022
Applications
Unspecified application
Species
Unspecified reactive species
Bioengineered 13:4051-4062 PubMed35129051
2022
Applications
Unspecified application
Species
Unspecified reactive species
Cell death & disease 13:77 PubMed35075115
2022
Applications
Unspecified application
Species
Unspecified reactive species
Bioengineered 13:844-855 PubMed34898378
2021
Applications
Unspecified application
Species
Unspecified reactive species
Product promise
Please note: All products are 'FOR RESEARCH USE ONLY. NOT FOR USE IN DIAGNOSTIC OR THERAPEUTIC PROCEDURES'.
For licensing inquiries, please contact partnerships@abcam.com